| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +2605213.26% |
| VRNA | Verona Pharma Plc | $77.75B | +1822670.15% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +1530490.86% |
| ARGX | Argen X SE | $54.32B | +1273495.95% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +917395.05% |
| ONC | BeiGene Ltd | $34.73B | +814196.82% |
| RVMD | Revolution Medicines Inc | $30.63B | +717950.70% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +552576.60% |
| BNTX | BioNTech SE | $23.52B | +551279.64% |
| INSM | Insmed Inc | $23.04B | +540018.82% |
| ROIV | Roivant Sciences Ltd | $21.31B | +499461.71% |
| INCY | Incyte Corp | $19.46B | +456205.02% |
| MRNA | Moderna Inc | $18.90B | +443033.58% |
| GMAB | Genmab | $17.06B | +399768.91% |
| ASND | Ascendis Pharma A/S | $15.18B | +355778.32% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +344654.50% |
| SMMT | Summit Therapeutics Inc | $13.47B | +315740.05% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +304748.12% |
| EXEL | Exelixis Inc | $12.69B | +297476.52% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +297410.59% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +284953.91% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +282623.36% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +260223.77% |
| ABVX | Abivax | $10.29B | +241063.35% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +237241.33% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +233162.99% |
| CYTK | Cytokinetics Inc | $9.51B | +222871.76% |
| KRYS | Krystal Biotech Inc | $9.03B | +211518.76% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +197952.61% |
| IBRX | ImmunityBio Inc | $8.26B | +193636.36% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +190660.81% |
| TECH | Bio-Techne Corp | $7.53B | +176365.47% |
| MTSR | Metsera Inc | $7.40B | +173500.19% |
| PCVX | Vaxcyte Inc | $7.36B | +172522.68% |
| CORT | Corcept Therapeutics Inc | $6.96B | +163089.49% |
| MRUS | Merus N.V | $6.83B | +159926.61% |
| IMVT | Immunovant Inc | $6.81B | +159644.39% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +157314.69% |
| ACLX | Arcellx Inc | $6.67B | +156181.13% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +153806.65% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +152156.67% |
| CELC | Celcuity Inc | $6.48B | +151754.11% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +146599.78% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | +144169.06% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +141305.14% |
| TGTX | TG Therapeutics Inc | $6.00B | +140598.63% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +139339.92% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +138926.16% |
| COGT | Cogent Biosciences Inc | $5.89B | +138069.50% |
| PTCT | PTC Therapeutics Inc | $5.86B | +137202.98% |
| APGE | Apogee Therapeutics Inc | $5.82B | +136397.94% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +133926.20% |
| BLTE | Belite Bio Inc | $5.59B | +130951.92% |
| CGON | Cg Oncology Inc | $5.35B | +125349.96% |
| LEGN | Legend Biotech Corp | $5.26B | +123334.21% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +122954.11% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +122001.30% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +120863.67% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +110809.86% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +110668.12% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +105501.67% |
| TVTX | Travere Therapeutics Inc | $4.41B | +103366.52% |
| AKRO | Akero Therapeutics Inc | $4.38B | +102591.72% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +101818.36% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +99878.32% |
| ERAS | Erasca Inc | $3.88B | +90766.35% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +90736.81% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +89616.54% |
| VKTX | Viking Therapeutics Inc | $3.67B | +85923.60% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +84894.72% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +84416.76% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +77260.65% |
| BEAM | Beam Therapeutics Inc | $3.28B | +76715.32% |
| DNLI | Denali Therapeutics Inc | $3.21B | +75074.35% |
| RCUS | Arcus Biosciences Inc | $3.01B | +70427.38% |
| DYN | Dyne Therapeutics Inc | $3.00B | +70235.63% |
| ORKA | ARCA biopharma Inc | $2.91B | +68106.00% |
| TNGX | Tango Therapeutics Inc | $2.83B | +66314.20% |
| GPCR | Structure Therapeutics Inc | $2.81B | +65781.71% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +64175.69% |
| RLAY | Relay Therapeutics Inc | $2.73B | +63911.08% |
| ALMS | Alumis Inc | $2.67B | +62434.94% |
| IRON | Disc Medicine Inc | $2.66B | +62360.78% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +61902.94% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +60478.00% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +60209.99% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +59014.59% |
| IMNM | Immunome Inc | $2.50B | +58563.96% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +57913.45% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +57328.03% |
| ETNB | 89bio Inc | $2.34B | +54829.74% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +53805.08% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +51882.15% |
| KOD | Kodiak Sciences Inc | $2.18B | +51034.05% |
| CLDX | Celldex Therapeutics Inc | $2.11B | +49295.97% |
| ZLAB | Zai Lab Ltd | $2.08B | +48548.48% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +47544.02% |
| MESO | Mesoblast Ltd | $2.02B | +47215.21% |
| TYRA | Tyra Biosciences Inc | $1.97B | +46147.38% |
| SION | Sionna Therapeutics Inc | $1.96B | +45796.31% |
| STOK | Stoke Therapeutics Inc | $1.96B | +45792.17% |
| NBTX | Nanobiotix | $1.94B | +45305.37% |
| AAPG | Ascentage Pharma Group International | $1.93B | +45209.94% |
| PHVS | Pharvaris NV | $1.92B | +45020.54% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +44785.61% |
| GLPG | Galapagos NV | $1.90B | +44404.44% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +44184.18% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +43727.18% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +43402.70% |
| ADMA | Adma Biologics Inc | $1.84B | +43032.02% |
| NVAX | Novavax Inc | $1.82B | +42650.28% |
| ZYME | Zymeworks BC Inc | $1.81B | +42386.98% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +42250.51% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +41631.71% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +41360.36% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +41184.52% |
| VCEL | Vericel Corp | $1.75B | +40884.10% |
| OCS | Oculis Holding AG | $1.74B | +40792.02% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +40608.22% |
| BHVN | Biohaven Ltd | $1.70B | +39737.78% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +39717.40% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +39336.28% |
| ANAB | AnaptysBio Inc | $1.67B | +39164.97% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +38914.58% |
| ABCL | AbCellera Biologics Inc | $1.65B | +38665.08% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +38627.06% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +38406.33% |
| INVA | Innoviva Inc | $1.63B | +38194.01% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +37852.74% |
| NKTR | Nektar Therapeutics | $1.62B | +37827.51% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +37797.23% |
| QURE | uniQure N.V. | $1.59B | +37096.23% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +36924.73% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +36576.99% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +36376.16% |
| PGEN | Precigen Inc | $1.55B | +36286.50% |
| IMTX | Immatics N.V | $1.53B | +35855.04% |
| ARDX | Ardelyx Inc | $1.52B | +35625.75% |
| MBX | MBX Biosciences Inc | $1.52B | +35455.08% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +35173.84% |
| VIR | Vir Biotechnology Inc | $1.47B | +34298.87% |
| IMCR | Immunocore Holdings plc | $1.45B | +33888.51% |
| URGN | UroGen Pharma Ltd | $1.43B | +33393.52% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +33062.75% |
| GHRS | GH Research PLC | $1.39B | +32419.79% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +32081.53% |
| SEPN | Septerna Inc | $1.34B | +31270.62% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +31220.42% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +30663.01% |
| MAZE | Maze Therapeutics Inc | $1.30B | +30276.57% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +29663.89% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +29080.22% |
| TRML | Tourmaline Bio Inc | $1.24B | +28871.29% |
| WVE | Wave Life Sciences Ltd | $1.22B | +28489.03% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +26357.78% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +26333.24% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +25648.02% |
| MNKD | Mannkind Corp | $1.10B | +25610.03% |
| DBVT | DBV Technologies | $1.10B | +25580.39% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +25391.24% |
| SVRA | Savara Inc | $1.07B | +24930.68% |
| JBIO | Jade Biosciences Inc | $1.06B | +24773.45% |
| CVAC | CureVac N.V. | $1.05B | +24500.73% |
| ANNX | Annexon Inc | $1.05B | +24440.54% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +23314.70% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +23107.20% |
| CGEM | Cullinan Oncology Inc | $953.73M | +22259.87% |
| PHAR | Pharming Group N.V. | $940.58M | +21951.75% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +21557.98% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +21324.71% |
| KURA | Kura Oncology Inc | $908.93M | +21209.73% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +21132.06% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +20716.93% |
| JANX | Janux Therapeutics Inc | $878.90M | +20505.54% |
| XNCR | Xencor Inc | $868.03M | +20250.77% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +19903.34% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +19688.59% |
| GERN | Geron Corp | $843.41M | +19673.61% |
| EVMN | Evommune Inc | $841.03M | +19617.73% |
| VOR | Vor Biopharma Inc | $840.96M | +19616.12% |
| TBPH | Theravance Biopharma Inc | $837.63M | +19538.13% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +19469.35% |
| SANA | Sana Biotechnology Inc | $825.64M | +19256.94% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +18784.81% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +18589.24% |
| OMER | Omeros Corporation | $797.02M | +18586.06% |
| ABSI | Absci Corp | $789.28M | +18404.57% |
| CMRX | Chimerix Inc | $766.03M | +17859.40% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +17753.26% |
| ANRO | Alto Neuroscience Inc | $714.55M | +16652.46% |
| ATXS | Astria Therapeutics Inc | $709.95M | +16544.64% |
| DSGN | Design Therapeutics Inc | $693.10M | +16149.57% |
| SLDB | Solid Biosciences Inc | $690.73M | +16094.03% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +15916.50% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +15734.84% |
| CRMD | CorMedix Inc | $663.22M | +15449.14% |
| IVA | Inventiva | $655.21M | +15261.36% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +15075.98% |
| CABA | Cabaletta Bio Inc | $640.38M | +14913.67% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +14895.51% |
| PRME | Prime Medicine Inc | $596.03M | +13873.81% |
| CADL | Candel Therapeutics Inc | $589.73M | +13725.99% |
| TECX | AvroBio Inc | $573.01M | +13334.09% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +13294.27% |
| ARVN | Arvinas Inc | $570.83M | +13282.86% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +12814.25% |
| VALN | Valneva SE | $545.52M | +12689.65% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +12625.49% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +12576.96% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +12520.29% |
| MDXG | Mimedx Group Inc | $537.64M | +12504.90% |
| PRTA | Prothena Corporation plc | $532.36M | +12381.16% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +12090.67% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +11665.44% |
| XOMA | XOMA Corp | $497.12M | +11554.80% |
| STRO | Sutro Biopharma Inc | $491.87M | +11431.74% |
| OCGN | Ocugen Inc | $466.88M | +10845.90% |
| SVA | Sinovac Biotech Ltd | $464.94M | +10800.38% |
| IMMX | Immix Biopharma Inc | $462.80M | +10750.14% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +10745.65% |
| STTK | Shattuck Labs Inc | $458.03M | +10638.31% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +10487.73% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +10483.23% |
| UPB | Upstream Bio Inc | $449.51M | +10438.64% |
| AUTL | Autolus Therapeutics plc | $447.12M | +10382.65% |
| ADCT | Adc Therapeutics SA | $438.08M | +10170.77% |
| ASMB | Assembly Biosciences Inc | $435.45M | +10109.04% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +10038.09% |
| AURA | Aura Biosciences Inc | $430.49M | +9992.72% |
| OVID | Ovid Therapeutics Inc | $424.86M | +9860.67% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +9737.34% |
| IPSC | Century Therapeutics Inc | $415.14M | +9632.77% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +9487.41% |
| CMPX | Compass Therapeutics Inc | $408.80M | +9484.22% |
| CYBN | Cybin Inc | $408.43M | +9475.59% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +9366.14% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +9353.29% |
| BNTC | Benitec Biopharma Inc | $398.51M | +9242.98% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +9050.12% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +9047.87% |
| CCCC | C4 Therapeutics Inc | $389.10M | +9022.26% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +9007.65% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +8886.72% |
| RVNC | Revance Therapeutics Inc | $380.38M | +8817.85% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +8811.55% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +8741.06% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +8738.30% |
| OABI | OmniAb Inc | $374.99M | +8691.56% |
| REPL | Replimune Group Inc | $374.27M | +8674.59% |
| ALT | Altimmune Inc | $373.67M | +8660.72% |
| VSTM | Verastem Inc | $373.33M | +8652.70% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +8643.11% |
| PBYI | Puma Biotechnology Inc | $371.93M | +8619.74% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +8473.00% |
| CLLS | Cellectis | $364.91M | +8455.33% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +8436.79% |
| EDIT | Editas Medicine Inc | $349.39M | +8091.26% |
| PALI | Palisade Bio Inc | $346.56M | +8025.09% |
| RGNX | Regenxbio Inc | $345.32M | +7995.89% |
| IMRX | Immuneering Corp Class A | $344.95M | +7987.38% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +7973.76% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +7948.19% |
| FBRX | Forte Biosciences Inc | $340.15M | +7874.79% |
| IMAB | I-Mab | $339.64M | +7862.69% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +7743.73% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +7606.02% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +7556.61% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +7549.55% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +7526.59% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +7486.02% |
| SLN | Silence Therapeutics Plc | $321.20M | +7430.35% |
| RZLT | Rezolute Inc | $319.69M | +7395.07% |
| IVVD | Invivyd Inc | $319.57M | +7392.21% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +7368.59% |
| ANL | Adlai Nortye Ltd | $317.46M | +7342.67% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +7052.06% |
| SCPH | scPharmaceuticals Inc | $304.59M | +7041.05% |
| NAGE | Niagen Bioscience Inc | $304.32M | +7034.72% |
| SRZN | Surrozen Inc | $304.03M | +7027.81% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +7000.53% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +6835.47% |
| IRD | Ocuphire Pharma Inc | $295.61M | +6830.42% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +6683.04% |
| ACIU | AC Immune SA | $289.11M | +6678.18% |
| TENX | Tenax Therapeutics Inc | $288.39M | +6661.31% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +6606.32% |
| YDES | YD Bio Ltd | $278.91M | +6438.97% |
| MGNX | Macrogenics Inc | $278.39M | +6426.86% |
| FATE | Fate Therapeutics Inc | $275.57M | +6360.58% |
| CNTX | Context Therapeutics Inc | $273.80M | +6319.18% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +6292.93% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +6212.13% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | +6082.38% |
| TARA | Protara Therapeutics Inc | $262.06M | +6044.04% |
| CGEN | Compugen Ltd | $260.97M | +6018.31% |
| TRDA | Entrada Therapeutics Inc | $257.38M | +5934.23% |
| CHRS | Coherus Biosciences Inc | $256.00M | +5901.89% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | +5896.56% |
| HUMA | Humacyte Inc | $255.32M | +5885.96% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | +5777.46% |
| ALEC | Alector Inc | $245.37M | +5652.54% |
| LENZ | LENZ Therapeutics Inc | $242.37M | +5582.30% |
| THRD | Third Harmonic Bio Inc | $241.86M | +5570.46% |
| CDXS | Codexis Inc | $239.96M | +5525.81% |
| VYGR | Voyager Therapeutics Inc | $237.02M | +5456.89% |
| ADAG | Adagene Inc | $236.93M | +5454.72% |
| NKTX | Nkarta Inc | $236.88M | +5453.67% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +5362.91% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | +5329.61% |
| NERV | Minerva Neurosciences Inc | $230.61M | +5306.57% |
| SLRN | Acelyrin Inc | $228.54M | +5258.17% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | +5189.13% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | +5162.31% |
| CRBU | Caribou Biosciences Inc | $223.96M | +5150.63% |
| KROS | Keros Therapeutics Inc | $223.18M | +5132.37% |
| RNA | Atrium Therapeutics Inc | $222.37M | +5113.49% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +5025.21% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | +5004.40% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | +4720.04% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | +4646.28% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +4631.30% |
| ELTX | Elicio Therapeutics Inc | $200.75M | +4606.58% |
| KRRO | Korro Bio Inc | $198.45M | +4552.72% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | +4537.73% |
| DTIL | Precision Biosciences Inc | $195.87M | +4492.05% |
| IMUX | Immunic Inc | $190.70M | +4370.94% |
| QTTB | Q32 Bio Inc | $187.99M | +4307.35% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | +4252.11% |
| MDWD | MediWound Ltd | $184.49M | +4225.22% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | +4201.13% |
| THAR | Tharimmune Inc | $183.00M | +4190.39% |
| IFRX | InflaRx N.V. | $182.18M | +4171.12% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +4139.08% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | +4083.28% |
| GALT | Galectin Therapeutics Inc | $177.81M | +4068.80% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +3968.67% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | +3946.55% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | +3946.46% |
| HRTX | Heron Therapeutics Inc | $172.54M | +3945.16% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | +3929.80% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | +3908.97% |
| SPRO | Spero Therapeutics Inc | $169.62M | +3876.75% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | +3868.72% |
| THTX | Theratechnologies Inc | $167.34M | +3823.17% |
| ANTX | AN2 Therapeutics Inc | $166.61M | +3806.21% |
| EQ | Equillium Inc | $166.29M | +3798.53% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | +3766.33% |
| PRQR | ProQR Therapeutics N.V | $164.37M | +3753.50% |
| MENS | Jyong Biotech Ltd | $164.22M | +3750.11% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | +3718.82% |
| IPHA | Innate Pharma | $159.97M | +3650.48% |
| TTRX | Turn Therapeutics Inc | $157.58M | +3594.40% |
| MOLN | Molecular Partners AG | $154.89M | +3531.26% |
| VXRT | Vaxart Inc | $153.61M | +3501.39% |
| HURA | TuHURA Biosciences Inc | $151.32M | +3447.59% |
| NBP | NovaBridge Biosciences. | $150.91M | +3438.10% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | +3428.63% |
| AKTX | Akari Therapeutics Plc | $148.12M | +3372.74% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +3307.85% |
| INDP | Indaptus Therapeutics Inc | $143.82M | +3271.77% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | +3258.63% |
| PROK | ProKidney Corp - Class A | $137.85M | +3131.86% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +3126.61% |
| GNLX | Genelux Corp | $137.21M | +3116.90% |
| GUTS | Fractyl Health Inc | $136.31M | +3095.78% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | +3003.32% |
| AGEN | Agenus Inc | $131.36M | +2979.69% |
| ACOG | Alpha Cognition Inc | $124.77M | +2825.10% |
| CRDF | Cardiff Oncology Inc | $123.75M | +2801.28% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | +2724.62% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | +2714.07% |
| SEER | Seer Inc - Class A | $115.64M | +2611.20% |
| ENGN | enGene Holdings Inc | $115.22M | +2601.35% |
| RPTX | Repare Therapeutics Inc | $113.91M | +2570.65% |
| COYA | Coya Therapeutics Inc | $111.89M | +2523.25% |
| PYXS | Pyxis Oncology Inc | $108.70M | +2448.40% |
| VANI | Vivani Medical Inc | $108.35M | +2440.23% |
| CGTX | Cognition Therapeutics Inc | $106.33M | +2392.91% |
| HLVX | HilleVax Inc | $104.74M | +2355.58% |
| ONCY | Oncolytics Biotech Inc | $104.52M | +2350.34% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | +2340.68% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | +2318.31% |
| PEPG | PepGen Inc | $103.13M | +2317.82% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +2300.82% |
| BMEA | Biomea Fusion Inc | $98.33M | +2205.26% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | +2192.98% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +2191.50% |
| ICCC | Immucell Corp | $96.17M | +2154.62% |
| PMN | ProMIS Neurosciences Inc | $93.94M | +2102.32% |
| ATHA | Athira Pharma Inc | $92.15M | +2060.44% |
| FBIO | Fortress Biotech Inc | $91.60M | +2047.43% |
| PTHS | Channel Therapeutics Corporation | $90.85M | +2030.02% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | +2003.38% |
| ANIX | Anixa Biosciences Inc | $88.68M | +1979.04% |
| EXOZ | Invizyne Technologies Inc | $88.10M | +1965.41% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | +1944.77% |
| AARD | Aardvark Therapeutics Inc | $87.05M | +1940.81% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +1939.47% |
| PYPD | Polypid Ltd | $86.83M | +1935.78% |
| NRXS | Neuraxis Inc | $85.30M | +1899.91% |
| LPTX | Leap Therapeutics Inc | $84.76M | +1887.15% |
| CSBR | Champions Oncology Inc | $82.35M | +1830.65% |
| ACET | Adicet Bio Inc | $81.58M | +1812.63% |
| HYFT | MindWalk Holdings Corp | $79.54M | +1764.84% |
| MAIA | MAIA Biotechnology Inc | $79.48M | +1763.38% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | +1726.89% |
| FBIOP | Fortress Biotech Inc | $77.72M | +1722.13% |
| RLYB | Rallybio Corp | $76.87M | +1702.13% |
| PLRX | Pliant Therapeutics Inc | $76.77M | +1699.95% |
| GANX | Gain Therapeutics Inc | $75.20M | +1663.16% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | +1650.94% |
| XBIT | XBiotech Inc | $74.39M | +1644.06% |
| OSTX | OS Therapies Inc | $74.24M | +1640.44% |
| MCRB | Seres Therapeutics Inc | $73.19M | +1615.91% |
| SAVA | Cassava Sciences Inc. | $72.46M | +1598.85% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +1586.29% |
| EDSA | Edesa Biotech Inc | $70.82M | +1560.34% |
| BYSI | BeyondSpring Inc | $70.31M | +1548.52% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | +1510.96% |
| SPRB | Spruce Biosciences Inc | $67.96M | +1493.19% |
| CUE | Cue Biopharma Inc | $66.52M | +1459.62% |
| IMA | Ikena Oncology Inc | $66.48M | +1458.67% |
| MNOV | Medicinova Inc | $65.46M | +1434.79% |
| IBIO | iBio Inc | $64.94M | +1422.55% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | +1407.89% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | +1400.42% |
| IMMP | Immutep Ltd | $63.92M | +1398.62% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +1389.99% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | +1382.70% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +1382.18% |
| PDSB | PDS Biotechnology Corporation | $61.96M | +1352.53% |
| OTLK | Outlook Therapeutics Inc | $61.25M | +1336.03% |
| GLTO | Galecto Inc | $60.81M | +1325.67% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +1287.92% |
| ANVS | Annovis Bio Inc | $57.22M | +1241.45% |
| DWTX | Virios Therapeutics Inc | $57.12M | +1239.09% |
| ENTX | Entera Bio Ltd | $55.48M | +1200.73% |
| TIL | Instil Bio Inc | $55.21M | +1194.28% |
| KZR | Kezar Life Sciences Inc | $53.76M | +1160.37% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | +1138.64% |
| MREO | Mereo Biopharma Group Plc | $52.71M | +1135.79% |
| NBY | Stablecoin Development Corp | $52.10M | +1121.43% |
| RNTX | Rein Therapeutics Inc | $51.79M | +1114.31% |
| GOSS | Gossamer Bio Inc | $51.14M | +1098.97% |
| MGX | Metagenomi Inc | $50.82M | +1091.55% |
| ACTU | Actuate Therapeutics Inc | $50.03M | +1072.98% |
| INKT | MiNK Therapeutics Inc | $48.84M | +1045.09% |
| ESLA | Estrella Immunopharma Inc | $48.44M | +1035.65% |
| XLO | Xilio Therapeutics Inc | $48.23M | +1030.66% |
| CING | Cingulate Inc | $47.16M | +1005.58% |
| ATYR | Atyr Pharma Inc | $46.89M | +999.28% |
| LVTX | LAVA Therapeutics NV | $45.77M | +973.10% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +972.05% |
| PSTV | Plus Therapeutics Inc | $45.56M | +968.23% |
| ATOS | Atossa Therapeutics Inc | $44.09M | +933.68% |
| KALA | Kala Bio Inc | $43.31M | +915.49% |
| RNXT | RenovoRx Inc | $41.96M | +883.69% |
| NTRB | Nutriband Inc | $41.39M | +870.41% |
| HYPD | Eyenovia Inc | $41.14M | +864.58% |
| FGEN | FibroGen Inc | $39.31M | +821.52% |
| NNVC | NanoViricides Inc | $37.88M | +788.13% |
| VERU | Veru Inc | $37.40M | +776.77% |
| LTRN | Lantern Pharma Inc | $37.25M | +773.39% |
| INMB | INmune Bio Inc | $37.22M | +772.60% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | +760.63% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +746.47% |
| GRCE | Acasti Pharma Inc | $36.05M | +745.29% |
| GBIO | Generation Bio Company | $35.97M | +743.27% |
| ABVC | ABVC BioPharma Inc | $35.82M | +739.72% |
| MURA | Mural Oncology plc | $35.34M | +728.60% |
| LITS | Lite Strategy Inc | $35.16M | +724.22% |
| ALGS | Aligos Therapeutics Inc | $34.65M | +712.45% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | +704.14% |
| DARE | Dare Bioscience Inc | $33.92M | +695.33% |
| EVAX | Evaxion Biotech A/S | $33.82M | +692.89% |
| BOLD | Boundless Bio Inc | $32.94M | +672.23% |
| SNTI | Senti Biosciences Inc | $31.46M | +637.48% |
| TVRD | Cara Therapeutics Inc | $30.96M | +625.81% |
| LSTA | Lisata Therapeutics Inc | $30.05M | +604.61% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | +602.71% |
| APLM | Apollomics Inc - Class A | $29.93M | +601.72% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | +583.38% |
| SKYE | Skye Bioscience Inc | $29.10M | +582.30% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | +580.78% |
| GRDX | Entero Therapeutics Inc | $28.95M | +578.80% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | +570.19% |
| CRVO | CervoMed Inc | $28.15M | +559.89% |
| IGC | IGC Pharma Inc | $28.00M | +556.43% |
| DYAI | Dyadic International Inc DE | $27.40M | +542.35% |
| ALLR | Allarity Therapeutics Inc | $27.37M | +541.61% |
| SER | AgeX Therapeutics Inc | $26.82M | +528.75% |
| PLRZ | Polyrizon Ltd | $26.52M | +521.76% |
| CELU | Celularity Inc - Class A | $26.39M | +518.69% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | +517.97% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | +517.05% |
| PTN | Palatin Technologies Inc | $26.08M | +511.34% |
| TPST | Tempest Therapeutics Inc | $25.68M | +501.96% |
| JSPR | Jasper Therapeutics Inc | $25.26M | +492.32% |
| PLUR | Pluri Inc | $24.62M | +477.13% |
| MRKR | Marker Therapeutics Inc | $24.21M | +467.72% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | +458.28% |
| VYNE | VYNE Therapeutics Inc | $22.68M | +431.65% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | +423.21% |
| HOTH | Hoth Therapeutics Inc | $22.13M | +418.78% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +414.75% |
| NXTC | Nextcure Inc | $21.90M | +413.39% |
| OPT | Opthea Ltd | $21.53M | +404.75% |
| CRIS | Curis Inc | $21.11M | +394.89% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +377.72% |
| LGVN | Longeveron Inc - Class A | $19.70M | +361.92% |
| GNTA | Genenta Science SpA | $19.23M | +350.75% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | +350.67% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | +343.08% |
| XCUR | Exicure Inc | $17.78M | +316.92% |
| INAB | IN8bio Inc | $17.72M | +315.55% |
| PASG | Passage Bio Inc | $17.71M | +315.14% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | +305.15% |
| MTVA | MetaVia Inc | $17.25M | +304.40% |
| LPCN | Lipocine Inc | $17.04M | +299.58% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | +288.04% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | +277.86% |
| HIND | ReShape Lifesciences Inc | $15.72M | +268.59% |
| COCP | Cocrystal Pharma Inc | $15.44M | +262.02% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | +261.98% |
| LEXX | Lexaria Bioscience Corp | $15.24M | +257.27% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +250.91% |
| QNCX | Quince Therapeutics Inc | $14.89M | +249.19% |
| APLT | Applied Therapeutics Inc | $14.86M | +248.46% |
| HOOK | Hookipa Pharma Inc | $14.68M | +244.11% |
| BLRX | Bioline Rx Ltd | $14.66M | +243.80% |
| MBRX | Moleculin Biotech Inc | $14.57M | +241.55% |
| IOBT | IO Biotech Inc | $14.50M | +239.91% |
| ICU | SeaStar Medical Holding Corp | $14.34M | +236.14% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | +231.66% |
| GTBP | GT Biopharma Inc | $13.91M | +226.06% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | +220.38% |
| TOVX | Theriva Biologics Inc | $13.51M | +216.65% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | +213.22% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +205.27% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | +204.53% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | +199.60% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | +189.16% |
| CALC | CalciMedica Inc | $11.72M | +174.88% |
| LNAI | Lunai Bioworks Inc | $11.72M | +174.67% |
| TRAW | Traws Pharma Inc | $11.70M | +174.24% |
| INTS | Intensity Therapeutics Inc | $11.33M | +165.65% |
| BIVI | BioVie Inc - Class A | $11.16M | +161.69% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | +161.22% |
| BRTX | BioRestorative Therapies Inc | $11.03M | +158.58% |
| APRE | Aprea Therapeutics Inc | $10.96M | +156.94% |
| KAPA | Kairos Pharma Ltd | $10.68M | +150.49% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | +144.45% |
| CVM | Cel-Sci Corp | $10.15M | +137.86% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | +137.42% |
| MLEC | Moolec Science SA | $10.06M | +135.79% |
| BCDA | BioCardia Inc | $9.85M | +130.92% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | +129.90% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | +128.10% |
| SNGX | Soligenix Inc | $9.11M | +113.48% |
| IMNN | Imunon Inc | $9.02M | +111.53% |
| EPIX | Essa Pharma Inc | $8.93M | +109.38% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | +109.07% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | +106.26% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | +104.06% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | +100.20% |
| IMRN | Immuron Ltd | $8.36M | +95.95% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | +91.29% |
| LIMN | Liminatus Pharma Inc | $8.08M | +89.39% |
| ITRM | Iterum Therapeutics Plc | $8.06M | +88.99% |
| NCNA | NuCana plc | $7.95M | +86.35% |
| ADXN | Addex Therapeutics Ltd | $7.90M | +85.18% |
| SYBX | Synlogic Inc | $7.72M | +81.02% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | +79.70% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | +71.99% |
| XBIO | Xenetic Biosciences Inc | $7.06M | +65.63% |
| GNPX | Genprex Inc | $7.02M | +64.62% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | +63.68% |
| EVGN | Evogene Ltd | $6.91M | +62.10% |
| SILO | SILO Pharma Inc | $6.78M | +59.03% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | +58.12% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | +56.69% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | +50.05% |
| GOVX | Geovax Labs Inc | $6.29M | +47.36% |
| APM | Aptorum Group Ltd - Class A | $6.26M | +46.66% |
| BCAB | BioAtla Inc | $6.19M | +45.13% |
| PPBT | Purple Biotech Ltd | $6.05M | +41.83% |
| APVO | Aptevo Therapeutics Inc | $5.83M | +36.59% |
| BGMS | Bio Green Med Solution Inc | $5.30M | +24.23% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | +23.10% |
| DRMA | Dermata Therapeutics Inc | $5.23M | +22.59% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | +21.42% |
| HCWB | HCW Biologics Inc | $5.10M | +19.51% |
| PULM | Pulmatrix Inc | $4.97M | +16.45% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | +15.11% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | +15.00% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | +9.72% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | +9.43% |
| ALZN | Alzamend Neuro Inc | $4.38M | +2.58% |
| MBIO | Mustang Bio Inc | $4.29M | +0.58% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -0.03% |
| REVB | Revelation Biosciences Inc | $4.26M | -0.12% |
| FBLG | FibroBiologics Inc | $4.23M | -0.93% |
| ENVB | Enveric Biosciences Inc | $4.15M | -2.64% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -2.98% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | -4.33% |
| PHGE | BiomX Inc | $3.91M | -8.43% |
| PBM | Psyence Biomedical Ltd | $3.76M | -11.78% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | -12.84% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | -15.43% |
| VIVS | VivoSim Labs Inc | $3.36M | -21.13% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -21.65% |
| AZTR | Azitra Inc | $3.32M | -22.14% |
| GRI | GRI Bio Inc | $3.30M | -22.71% |
| SPRC | SciSparc Ltd | $3.05M | -28.60% |
| AFMD | Affimed N.V. | $2.98M | -30.25% |
| CMND | Clearmind Medicine Inc | $2.88M | -32.43% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -32.57% |
| ARTL | Artelo Biosciences Inc | $2.75M | -35.62% |
| OGEN | Oragenics Inc | $2.58M | -39.58% |
| PPCB | Propanc Biopharma Inc | $2.50M | -41.35% |
| NTBL | Notable Labs Inc Ord | $2.39M | -43.86% |
| BBLG | Bone Biologics Corp | $2.23M | -47.81% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -49.69% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -51.05% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -53.24% |
| AIM | AIM ImmunoTech Inc. | $1.74M | -59.11% |
| ONCO | Onconetix Inc | $1.61M | -62.21% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -63.46% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -63.56% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -63.58% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -64.38% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -66.55% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -67.54% |
| JAGX | Jaguar Health Inc | $1.34M | -68.50% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -69.48% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -76.38% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -78.43% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -87.08% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -89.52% |
| ELAB | PMGC Holdings Inc | $221376.00 | -94.81% |
| ADTX | Aditxt Inc | $132564.52 | -96.89% |
| CDT | CDT Equity Inc | $110551.31 | -97.41% |